Peter Galen

Hemex Health, Inc.

NIH Rank #7642
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$1.6M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#7,642
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.6M across 3 grants · National rank #7642.

Top grants by award amount

Peter Galen's NIH grant portfolio, ranked by award amount.

  • 5R44HL140739-05R44
    Affordable, quantitative, point-of-care microchip-electrophoresis for screening and treatment monitoring of sickle cell disease, thalassemias, and anemias
    $995.5K
    award amount
  • 1R43NS135862-01R43
    Using an Inclined Plane System to Triage TBI Patients
    $332.1K
    award amount
  • 1R41HL172662-01R41
    RHODA: Rapid Hemoglobin-Oxygen Dissociation Assay
    $295.9K
    award amount

Affiliation

Institutions that have administered grants for Peter Galen.

Affiliated with Hemex Health, Inc. (OR).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Hemex Health, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #7642

Related investigators

Other NIH-funded PIs frequently associated with Peter Galen.